BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 33586001)

  • 1. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.
    Carrillo-López N; Martínez-Arias L; Fernández-Villabrille S; Ruiz-Torres MP; Dusso A; Cannata-Andía JB; Naves-Díaz M; Panizo S;
    Calcif Tissue Int; 2021 Apr; 108(4):439-451. PubMed ID: 33586001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
    Carrillo-López N; Martínez-Arias L; Alonso-Montes C; Martín-Carro B; Martín-Vírgala J; Ruiz-Ortega M; Fernández-Martín JL; Dusso AS; Rodriguez-García M; Naves-Díaz M; Cannata-Andía JB; Panizo S
    Nephrol Dial Transplant; 2021 Mar; 36(4):618-631. PubMed ID: 33367746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The key role of proinflammatory cytokines, matrix proteins, RANKL/OPG and Wnt/β-catenin in bone healing of hip arthroplasty patients.
    Cassuto J; Folestad A; Göthlin J; Malchau H; Kärrholm J
    Bone; 2018 Feb; 107():66-77. PubMed ID: 29129760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction.
    Fernández-Villabrille S; Martín-Vírgala J; Martín-Carro B; Baena-Huerta F; González-García N; Gil-Peña H; Rodríguez-García M; Fernández-Gómez JM; Fernández-Martín JL; Alonso-Montes C; Naves-Díaz M; Carrillo-López N; Panizo S
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
    Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
    Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study.
    Catalano A; Loddo S; Bellone F; Pecora C; Lasco A; Morabito N
    Bone; 2018 Nov; 116():42-46. PubMed ID: 30010081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum PTH, PTH1R/ATF4 pathway, and the sRANKL/OPG system in bone as a new link between bone growth, cross-sectional geometry, and strength in young rats with experimental chronic kidney disease.
    Sieklucka B; Pawlak D; Domaniewski T; Hermanowicz J; Lipowicz P; Doroszko M; Pawlak K
    Cytokine; 2021 Dec; 148():155685. PubMed ID: 34411988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.
    Vega D; Maalouf NM; Sakhaee K
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4514-21. PubMed ID: 17895323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
    Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures.
    Lee SK; Lorenzo JA
    Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.
    Hofbauer LC; Heufelder AE
    J Mol Med (Berl); 2001 Jun; 79(5-6):243-53. PubMed ID: 11485016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid β peptide promotes bone formation by regulating Wnt/β-catenin signaling and the OPG/RANKL/RANK system.
    Yang B; Li S; Chen Z; Feng F; He L; Liu B; He T; Wang X; Chen R; Chen Z; Xie P; Rong L
    FASEB J; 2020 Mar; 34(3):3583-3593. PubMed ID: 31944393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
    J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    Kiechl S; Werner P; Knoflach M; Furtner M; Willeit J; Schett G
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):801-11. PubMed ID: 17173497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target.
    Amin N; Clark CCT; Taghizadeh M; Djafarnejad S
    J Trace Elem Med Biol; 2020 Jan; 57():126417. PubMed ID: 31653549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D.
    Karalazou P; Ntelios D; Chatzopoulou F; Fragou A; Taousani M; Mouzaki K; Galli-Tsinopoulou A; Kouidou S; Tzimagiorgis G
    Ital J Pediatr; 2019 Dec; 45(1):161. PubMed ID: 31823791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis and vascular calcification in rheumatoid arthritis - the role of osteoprotegerin and sclerostin].
    Krajewska-Włodarczyk M; Stompór T
    Pol Merkur Lekarski; 2017 Jul; 43(253):41-47. PubMed ID: 28805201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.